Funny how if you speak the truth about obama you are a racist. I forgot his people don't like the truth.
You can keep you health plan
You can keep you Dr.
I don't know uncle omar
Bengazi was due to a video
Fast and furious
My leadership will be transparent
I work with many differect races and have never been called a racist. Sorry that your leader is such a lousy el presidente but when you are a liar you fry.
How are his poll numbers doing? lol loser!
Looks like Cruz was right.
Millions of Americans losing their coverage, premiums in the exchange alot more.
Then you get the most transparent presidency. Fast and Furious-coverup. Bengazi cover up. His God bless Planned Parenthood seriuosly! God blessing murder of the innocents! If you like your insurance you can keep your insurance-LIAR! IF you like you Doctor you can keep your Doctor-Liar!
Barack Hussien- get that Hussien- sounds like a muslim sent to destroy America.
Impeach the Bum!
In short, Adcom meeting.
AMRN hit all primary and secondary endpoints, panel said safety was good and has reduce -it study more than half enrolled; these were the requirements from the SPA.
The question voted on will Vascepa reduce cardio events. Predicting that wasn't in the SPA that is what reduce it was for. It was voted 2-9 against.
The question should have been does it lower triglicerydes in the 200-500 range. That was the trial.
PDUFA is Dec 20th holding out hope. The fda goes against the panel 25% of the time. During cc AMRN said legal would be spending alot of time is DC.
Will even hold after that hoping Vascepa sales ramp up for the Marine trial that was approved. Vascepa beats the snot out of Lovaza. If it doesn't get approved they need to stop the Reduce-It trial to save cash. Approx 263M on hand but alot of debt.
If it is Crede which is shorting the stock to get the stock under 2.00 and hold it under until March 24. I think they will get their hat handed to them if we get EMEA approval. If we don't then it is bad for us.
EU approvalis the main catalyst right now. EMEA for all cancer types will get us a nice EU dist. deal with cash milestone and it is off to the races. Then the sNDA gets filed by year end and Rigs IND. Not to mention the other catalysts that are on the link on the old timers board.
Bought a little more last week. Trying to make up for that AMRN fiasco. I still am holding it but have a bunch that I bought at approx $7.
Sentiment: Strong Buy
From the latest CEO interview
Recent presentation, from transcript: "We are seeing very nice adoption and utilization curves. We are paying a lot of attention to key qualitative metrics like formulary replacement, adoption a key academic medical institutions, repeat ordering from users, multi ordering from users, all of those are boiling to a very nice scenario now"
Marty had alot of other premises that were wrong just read his SA article-The Short Case for Neoprobe: Skeptical of Its Primary Asset's Success He predicted $.25 by May 2012.
Have been in the stock since $.20 and traded around a long postion. It has been the best stock I have ever owned and I had DNDN from 3 and 5 and sold at 25 and 36 too impatient for 57 and never bought again, Amln from 10 to 28 didn't wait for buyout in case it fell through and Amrn-which I have been buying for adacom again- from 8-16. Oh yeah MNTA 12-25.
Disclosure on the worst stocks I ever owned SUF 2-bk, GBIX 6-bk
I also own Arna now been buying from 7.50 down to 4.20 and think this will be a great stock. Too many lazy Americans.
I still think the best is yet to come for Navb.